Pharmaceutical supply contracts

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline Feb 01, 2028 · 528 days left·Open·Supplies·Framework

Structured notice only

Original notice title

Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption

40/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

40 / 100

Complexity

60 / 100

Risk factors

No award criteria, eligibility criteria, or required documents are specified, making it impossible to assess requiremen...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal protections for...

No procurement documents available

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
3 lots
Duration until Mar 2028
Supply of pharmaceutical products (medicinal products) for 12 specific active substances
Framework agreement with opt-in option (Beitrittsoption) allowing additional parties to join

Show full summary

This is a framework agreement with opt-in option (Rahmenvertrag mit Beitrittsoption) for pharmaceutical products across 12 lots covering specific active substances (e.g., Adalimumab, Apremilast, Budesonide, etc.). The notice explicitly states it is not a public procurement under EU directives (voluntary publication). The buyer is BARMER Beschaffung und Vergabe, performance location is Wuppertal, Germany. No estimated value, award criteria, eligibility criteria, or required documents are specified. Submission deadline is 2028-02-01 via electronic means. There is an inconsistency in EU funding flag (structured data says EU-funded, XML says no EU funds).

Risks

No award criteria, eligibility criteria, or required documents are specified, making it impossible to assess requiremen...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal protections for...

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Administrative

Electronic submission via Open portal
Procurement documents are available only electronically and free of charge
Tenders must be submitted in German (notice language DEU)

Requirements may be incomplete.

Buyer

Name

BARMER Beschaffung und Vergabe

Location

Wuppertal, Germany

Duration

Apr 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0006

Estradiol (GEL)

Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

Apr 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0007

Etanercept

Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

Apr 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0008

Hepatitis-B-Immunglobulin vom Menschen (Zutectra®)

Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

Apr 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0009

Mercaptamin (HKP)

Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

Apr 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0010

Omalizumab

Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

Apr 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0011

Somatropin

Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

Apr 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0012

Vandetanib

Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

Apr 2026 - Mar 2028

Category

Pharmaceutical products

Procurement Details

Publication date: 23 Mar 2026
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 202213-2026

Documents (1)

Submission portal 1

Similar tenders

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

40/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

40 / 100

Complexity

60 / 100